The University Hospital of Giessen and Marburg is a German university hospital based in Giessen and Marburg. The Giessen site is the teaching hospital of the University of Giessen whereas the Marburg site is the teaching hospital of the University of Marburg.

During the past decade, Universitätsklinikum Marburg conducted 135 clinical trials. In the 10-year time frame, 135 clinical trials started and 41 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 35 clinical trials were completed. i.e. 54.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Marburg" #1 sponsor was "Boehringer Ingelheim" with 11 trials, followed by "University of Ulm" with 9 trials sponsored, "Actelion" with 7 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored and "Hoffmann-La Roche" with 6 trials sponsored. Other sponsors include 167 different institutions and companies that sponsored additional 121 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Marburg" #1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 4 trials as a collaborator, "Abbott" with 3 trials as a collaborator, "Charite University, Berlin, Germany" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "Hannover Medical School" with 3 trials as a collaborator. Other collaborators include 111 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Marburg" are "Acute Myeloid Leukemia" (9 trials), "Heart Failure" (9 trials), "Pulmonary Arterial Hypertension" (8 trials), "Coronary Artery Disease" (7 trials) and "Lymphoma" (6 trials). Many other conditions were trialed in "Universitätsklinikum Marburg" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Marburg" are "Drug" (134 trials), "Device" (38 trials), "Other" (23 trials), "Procedure" (21 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "cyclophosphamide" (9 trials), "radiation therapy" (8 trials), "Cytarabine" (7 trials) and "vincristine sulfate" (7 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Marburg" are 201 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 79 active trials in "Universitätsklinikum Marburg". 2 are not yet recruiting, 54 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 97 completed trials in Universitätsklinikum Marburg, undefined suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Marburg, 9 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 30 trials that are defined as “Not Applicable".

Universitätsklinikum Marburg has several departments that took part in Clinical trials: "Klinikum der Justus-Liebig-Universität, Zentrum für Kinderheilkunde, Abt. Hämatologie/Onkologie" - 4 trials, "Universitätsklinikum Giessen - Pediatric Heart Center" - 2 trials, "Universitaetsklinikum Marburg; Klinik fuer Neurologie" - 3 trials, "Philipps-Universität Marburg; Klinik für Innere Med.; Schwerpunkt Hämatologie/Onkologie/Immunologie" - 3 trials, "Universitätsklinikum Standort Gießen Medizinische Klinik II u. Poliklinik Innere Med./Pneumologie" - 3 trials, "Universitätsklinikum Marburg Klinik f. Dermatologie" - 2 trials, "Universitätsklinikum Gießen/Marburg Standort Marburg-Kardiologie" - 2 trials, "Universitätsklinikum Gießen und Marburg GmbH; Neurologie" - 2 trials